Endothelial activation, dysfunction and permeability during severe infections

Current Opinion in Hematology

Volumn 18, Issue 3, 2011, Pages 191-196

  Lee, Warren L ^a   Liles, W Conrad ^b,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

angiopoietin 1; angiopoietin 2; endothelial activation; endothelial permeability; sepsis

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2;

ARTICLE; DISEASE SEVERITY; EDEMA; ENDOTHELIUM LESION; HUMAN; INFLAMMATION; MALARIA; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOGENESIS; PERMEABILITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; SEPSIS; SHOCK; TOXIC SHOCK SYNDROME; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIAL CELLS; HUMANS; PERMEABILITY; SEPSIS;

EID: 79955017821     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328345a3d1     Document Type: Article

References (66)

1. Andonegui G, Zhou H, Bullard D, etal. Mice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic Gram-negative bacterial infection. J Clin Invest 2009; 119:1921-1930.
2. Shapiro NI, Schuetz P, Yano K, et al. The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care 2010; 14:R182.
3. Parikh SM, Mammoto T, Schultz A, et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006; 3:e46.
4. Fiedler U, Reiss Y, Scharpfenecker M, et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 2006; 12:235-239. (Pubitemid 43214752)
5. Kumpers P, Hafer C, David S, etal. Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome. Intensive Care Med 2009; 36:462-470.
6. Van der Heijden M, van Nieuw Amerongen GP, Koolwijk P, et al. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and nonseptic critically ill patients. Thorax 2008; 63:903-909.
7. Orfanos SE, Kotanidou A, Glynos C, et al. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med 2007; 35:199-206. (Pubitemid 46035696)
8. Mankhambo LA, Banda DL, Jeffers G, et al. The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children. Crit Care 2010; 14:R91.
9. SinerJM, Bhandari V, Engle KM, etal. Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis. Shock 2009; 31:348-353.
10. Kranidioti H, Orfanos SE, Vaki I, etal. Angiopoietin-2 is increased in septic shock: evidence for the existence of a circulating factor stimulating its release from human monocytes. Immunol Lett 2009; 125:65-71.
11. Van der Heijden M, Pickkers P, van Nieuw Amerongen GP, et al. Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med 2009; 35:1567-1574.
12. KumpersP,van Meurs M, David S, et al. Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis. Crit Care 2009; 13: R64.
13. Ricciuto DR, Dos Santos CC, Hawkes M, et al. Angiopoietin-1 and angiopoietin-2 as clinically informative biomarkers of morbidity and mortality in severe sepsis. Crit Care Med 2011 [Epub ahead of print].
14. Lovegrove FE, Tangpukdee N, Opoka RO, et al. Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One 2009; 4:e4912.
15. Conroy AL, Lafferty EI, Lovegrove FE, et al. Whole blood angiopoietin-1 and angiopoietin-2 levels discriminate cerebral and severe (noncerebral) malaria from uncomplicated malaria. Malar J 2009; 8:295.
16. Page AV, Kotb M, Low DE, et al. Systemic dysregulation of angiopopietin-1/2 in streptococcal toxic shock syndrome. Clin Infect Dis (in press).
17. Secor D, Li F, Ellis CG, et al. Impaired microvascular perfusion in sepsis requires activated coagulation and P-selectin-mediated platelet adhesion in capillaries. Intensive Care Med 2010; 36:1928-1934.
18. Bockmeyer CL, Reuken PA, Simon TP, et al. ADAMTS13 activity is decreased in a septic porcine model. Significance for glomerular thrombus deposition. Thromb Haemost 2011; 105:145-153.
19. Sadler JE. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 2008; 112:11-18.
20. Chauhan AK, Walsh MT, Zhu G, et al. The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis. Blood 2008; 111:3452-3457.
21. Viemann D, Schmolke M, Lueken A, et al. H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response. J Immunol 2011; 186:164-173.
22. Minami T, Yano K, Miura M, et al. The Down syndrome critical region gene 1 short variant promoters direct vascular bed-specific gene expression during inflammation in mice. J Clin Invest 2009; 119:2257-2270.
23. Ye X, Ding J, Zhou X, et al. Divergent roles of endothelial NF-kappaB in multiple organ injury and bacterial clearance in mouse models of sepsis. J Exp Med 2008; 205:1303-1315. (Pubitemid 351831488)
24. Xu H, Ye X, Steinberg H, Liu SF. Selective blockade of endothelial NF-kappaB pathway differentially affects systemic inflammation and multiple organ dysfunction and injury in septic mice. J Pathol 2010; 220:490-498.
25. Corada M, Mariotti M, Thurston G, et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci USA 1999; 96:9815-9820. (Pubitemid 29398815)
26. Jones CA, London NR, Chen H, et al. Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat Med 2008; 14:448-453. (Pubitemid 351499393)
27. London NR, Zhu W, Bozza FA, et al. Targeting Robo4-dependent slit signaling to survive the cytokine storm in sepsis and influenza. Sci Transl Med 2010; 2:23ra19.
28. Gavard J, HouX, Qu Y, etal.A roleforaCXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability. Mol Cell Biol 2009; 29:2469-2480.
29. Gavard J, Patel V, Gutkind JS. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 2008; 14:25-36.
30. Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 2008; 121:2115-2122.
31. Groger M, Pasteiner W, Ignatyev G, et al. Peptide Bbeta(15-42) preserves endothelial barrier function in shock. PLoS One 2009; 4:e5391.
32. Hoang MV, Nagy JA, Senger DR. Active Rac1 improves pathological VEGF neovessel architecture and reduces vascular leak: mechanistic similarities with angiopoietin-1. Blood 2010 [Epub ahead of print].
33. Toussaint S, Gerlach H. Activated protein C for sepsis. N Engl J Med 2009; 361:2646-2652.
34. Kerschen EJ, Fernandez JA, Cooley BC, et al. Endotoxemia and sepsis mortality reduction by nonanticoagulant activated protein C. J Exp Med 2007; 204:2439-2448. (Pubitemid 47529328)
35. Niessen F, Furlan-Freguia C, Fernandez JA, et al. Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality. Blood 2009; 113:2859-2866.
36. Riewald M, Petrovan RJ, Donner A, etal. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 2002; 296:1880-1882. (Pubitemid 34596276)
37. Song D, Ye X, Xu H, Liu SF. Activation of endothelial intrinsic NF-kappaB pathway impairs protein C anticoagulation mechanism and promotes coagulation in endotoxemic mice. Blood 2009; 114:2521-2529.
38. Garcia JG, Liu F, Verin AD, et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 2001; 108:689-701. (Pubitemid 32906197)
39. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006; 86:279-367.
40. Rosen H, Sanna MG, Cahalan SM, Gonzalez-Cabrera PJ. Tipping the gatekeeper: S1P regulation of endothelial barrier function. Trends Immunol 2007; 28:102-107. (Pubitemid 46283694)
41. Camerer E, Regard JB, Cornelissen I, etal. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest 2009; 119:1871-1879.
42. Puneet P, Yap CT, Wong L, et al. SphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis. Science 2010; 328:1290-1294.
43. Shea BS, Brooks SF, Fontaine BA, etal. Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury. Am J Respir Cell Mol Biol 2010; 43:662-673.
44. Jang C, Koh YJ, Lim NK, et al. Angiopoietin-2 exocytosis is stimulated by sphingosine-1-phosphate in human blood and lymphatic endothelial cells. Arterioscler Thromb Vasc Biol 2009; 29:401-407.
45. Xu J, Zhang X, Pelayo R, et al. Extracellular histones are major mediators of death in sepsis. Nat Med 2009; 15:1318-1321.
46. Hu H, Li X, Li Y, et al. Calpain-1 induces apoptosis in pulmonary microvascular endothelial cells under septic conditions. Microvasc Res 2009; 78:33-39.
47. Shioiri T, Muroi M, Hatao F, etal. Caspase-3 is activated and rapidly released from human umbilical vein endothelial cells in response to lipopolysaccharide. Biochim Biophys Acta 2009; 1792:1011-1018.
48. Matsuda N, Takano Y, Kageyama S, et al. Silencing of caspase-8 and caspase-3 by RNA interference prevents vascular endothelial cell injury in mice with endotoxic shock. Cardiovasc Res 2007; 76:132-140. (Pubitemid 47362040)
49. Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18:3964-3972. (Pubitemid 29335849)
50. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348:593-600. (Pubitemid 36204953)
51. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97:3422-3427. (Pubitemid 30183318)
52. Burnham EL, Taylor WR, Quyyumi AA, etal. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med 2005; 172:854-860. (Pubitemid 41369069)
53. Rafat N, Hanusch C, Brinkkoetter PT, etal. Increased circulating endothelial progenitor cells in septic patients: correlation with survival. Crit Care Med 2007; 35:1677-1684. (Pubitemid 46985869)
54. LuoTH, Wang Y, Lu ZM, et al. The change and effect of endothelial progenitor cells in pig with multiple organ dysfunction syndromes. Crit Care 2009; 13:R118.
55. Kahler CM, Wechselberger J, Hilbe W, et al. Peripheral infusion of rat bone marrow derived endothelial progenitor cells leads to homing in acute lung injury. Respir Res 2007; 8:50.
56. Kirton JP, Xu Q. Endothelial precursors in vascular repair. Microvasc Res 2010; 79:193-199.
57. Gupta N,Su X, Popov B, etal. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007; 179:1855-1863.
58. Mei SH, McCarter SD, Deng Y, et al. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 2007; 4:e269.
59. Xu J, Woods CR, Mora AL, et al. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 2007; 293:L131-141. (Pubitemid 47080721)
60. Lee JW, Fang X, Gupta N, et al. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 2009; 106:16357-16362.
61. Mei SH, Haitsma JJ, Dos Santos CC, et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 2010; 182:1047-1057.
62. Weil BR, Manukyan MC, Herrmann JL, et al. Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myo-cardial inflammation during endotoxemia. Surgery 2010; 148:444-452.
63. Weil BR, Markel TA, Herrmann JL, et al. Stem cells in sepsis. Ann Surg 2009; 250:19-27.
64. Nemeth K, Leelahavanichkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15:42-49.
65. Chen L, Tredget EE, Wu PY, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008; 3:e1886.
66. Rojas M, XuJ,Woods CR,et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol. 2005; 33: